SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-107219
Filing Date
2024-10-09
Accepted
2024-10-09 08:45:26
Documents
15
Period of Report
2024-10-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2425851d1_8k.htm   iXBRL 8-K 28652
2 EXHIBIT 99.1 tm2425851d1_ex99-1.htm EX-99.1 16510
6 GRAPHIC tm2425851d1_ex99-1img01.jpg GRAPHIC 3738
  Complete submission text file 0001104659-24-107219.txt   230992

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA apre-20241009.xsd EX-101.SCH 3006
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE apre-20241009_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apre-20241009_pre.xml EX-101.PRE 22353
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2425851d1_8k_htm.xml XML 3684
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 241361586
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)